loader from loading.io

Podcast 914: Neuroleptic Malignant Syndrome (NMS)

Emergency Medical Minute

Release Date: 07/29/2024

Episode 950: Ultrasound Pulse Check During Cardiac Arrest show art Episode 950: Ultrasound Pulse Check During Cardiac Arrest

Emergency Medical Minute

Contributor: Aaron Lessen, MD Educational Pearls: Point-of-care ultrasound (POCUS) is used to assess cardiac activity during cardiac arrest and can identify potential reversible causes such as pericardial tamponade Ultrasound could be beneficial in another way during cardiac arrest as well: pulse checks Manual palpation for detecting pulses is imperfect, with false positives and negatives Doppler ultrasound can be used as an adjunct or replacement to manual palpation for improved accuracy Options for Doppler ultrasound of carotid or femoral pulses during cardiac arrest: ...

info_outline
Episode 949: Hoover's Sign show art Episode 949: Hoover's Sign

Emergency Medical Minute

Contributor: Travis Barlock, MD Educational Pearls: What is Hoover’s sign used to identify? This physical exam maneuver differentiates between organic vs. functional (previously known as psychogenic) leg weakness. Organic causes include disease processes such as stroke, MS, spinal cord compression, guillain-barre, ALS, and sciatica, among others In Functional Neurologic Disorder, the dysfunction is in brain signaling, and treatment relies on more of a psychiatric approach How is Hoover's Sign performed? Place your hand under the heel of the unaffected leg and ask the patient to...

info_outline
Episode 948: CYP Inducers and Inhibitors show art Episode 948: CYP Inducers and Inhibitors

Emergency Medical Minute

Contributor: Jorge Chalit-Hernandez, OMS3 Educational Pearls: CYP enzymes are responsible for the metabolism of many medications, drugs, and other substances CYP3A4 is responsible for the majority Other common ones include CYP2D6 (antidepressants), CYP2E1 (alcohol), and CYP1A2 (cigarettes) CYP inducers lead to reduced concentrations of a particular medication CYP inhibitors effectively increase concentrations of certain medications in the body Examples of CYP inducers Phenobarbital Rifampin  Cigarettes St. John’s Wort Examples of CYP inhibitors -azole...

info_outline
Episode 947: Hypercapnia show art Episode 947: Hypercapnia

Emergency Medical Minute

Educational Pearls: Physiologic stimulation of ventilation occurs through changes in levels of: Arterial carbon dioxide (PaCO2) Arterial oxygen (PaO2) Hypercapnia is an elevated level of CO2 in the blood - this primarily drives ventilation Hypoxia is a decreased level of O2 in the body’s tissues - the backup drive for ventilation Patients at risk of hypercapnia should maintain an O2 saturation between 88-92% Normal O2 saturation is 95-100% In patients who chronically retain CO2, their main drive for ventilation becomes hypoxia An audit was performed of SpO2 observations...

info_outline
Episode 946: Time to Defibrillation show art Episode 946: Time to Defibrillation

Emergency Medical Minute

Contributor: Aaron Lessen, MD Educational Pearls: Quick background info Cardiac arrest is when the heart stops pumping blood for any reason. This is different from a heart attack in which the heart is still working but the muscle itself is starting to die. One cause of cardiac arrest is when the electrical signals are very disrupted in the heart and start following chaotic patterns such as Ventricular tachycardia (VTach) and Ventricular fibrillation (VFib) One of the only ways to save a person whose heart is in VFib or VTach is to jolt the heart with electricity and terminate the...

info_outline
Episode 945: Ketorolac vs. Ibuprofen show art Episode 945: Ketorolac vs. Ibuprofen

Emergency Medical Minute

Contributor: Ricky Dhaliwal, MD Educational Pearls:  Ketorolac and ibuprofen are NSAIDs with equivalent efficacy for pain in the emergency department Oral ibuprofen provides the same relief as intramuscular ketorolac IM ketorolac is associated with the adverse effect of a painful injection IM ketorolac is slightly faster in onset but not significant Studies have assessed the two medications in head-to-head randomized-controlled trials and found no significant difference in pain scores IM ketorolac takes longer to administer and has a higher cost Ketorolac dosing ...

info_outline
Episode 944: Colchicine Overdose show art Episode 944: Colchicine Overdose

Emergency Medical Minute

Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin between effective dose and toxic dose Colchicine overdoses can be unintentional or intentional and are associated with poor outcomes Phase 1: 10 - 24 hours after ingestion Patient looks well but may have mild symptoms mimicking gastroenteritis Phase 2: 24 hours - 7 days after ingestion ...

info_outline
Episode 943: Portal Vein Thrombosis show art Episode 943: Portal Vein Thrombosis

Emergency Medical Minute

Contributor: Travis Barlock, MD Educational Pearls: What is Portal Vein Thrombosis? The formation of a blood clot within the portal vein, which carries blood from the gastrointestinal tract, pancreas, and spleen to the liver Not only can this cause problems downstream in the liver, but the backup of venous blood can cause ischemia in the bowels How does it present? Similar to acute mesenteric ischemia: Sudden onset of abdominal pain, nausea, vomiting, and fever How is it diagnosed? Abdominal CT or MRI with contrast What causes it? Cirrhosis Coagulopathy (Factor V Leiden...

info_outline
Episode 942: Acute Mountain Sickness and High Altitude Cerebral Edema show art Episode 942: Acute Mountain Sickness and High Altitude Cerebral Edema

Emergency Medical Minute

Contributor: Jorge Chalit-Hernandez, OMS3 Educational Pearls: Acute mountain sickness (AMS) is the term given to what is otherwise colloquially known as altitude sickness High altitude cerebral edema (HACE) is a severe form of AMS marked by encephalopathic changes Symptoms begin at elevations as low as 6500 feet above sea level for people who ascend rapidly May develop more severe symptoms at higher altitudes The pathophysiology involves cerebral vasodilation Occurs in everyone ascending to high altitudes but is more pronounces in those that develop symptoms The reduced...

info_outline
Episode 941: Rehydration in Pediatric Gastroenteritis show art Episode 941: Rehydration in Pediatric Gastroenteritis

Emergency Medical Minute

Contributor: Meghan Hurley, MD Educational Pearls: Gastroenteritis clinical diagnoses: Diarrhea with or without vomiting and fever Vomiting in the absence of diarrhea has a large list of differential diagnoses, so the combination of diarrhea and vomiting in a patient is helpful to indicate the gastroenteritis diagnosis Symptom timeline is usually 1-3 days, but can last up to 14 days – diarrhea persists the longest Treatment for mild to moderate dehydration: oral or IV rehydration Begin orally to avoid unnecessary IV in a pediatric patient Administer ODT Ondansetron...

info_outline
 
More Episodes

Contributor: Taylor Lynch, MD

Educational Pearls:

What is NMS?

  • Neuroleptic Malignant Syndrome

  • Caused by anti-dopamine medication or rapid withdrawal of pro-dopamenergic medications

  • Mechanism is poorly understood

  • Life threatening

What medications can cause it?

  • Typical antipsychotics

    • Haloperidol, chlorpromazine, prochlorperazine, fluphenazine, trifluoperazine

  • Atypical antipsychotics

    • Less risk

    • Risperidone, clozapine, quetiapine, olanzapine, aripiprazole, ziprasidone

  • Anti-emetic agents with anti dopamine activity

    • Metoclopramide, promethazine, haloperidol

    • Not ondansetron

  • Abrupt withdrawal of levodopa

How does it present?

  • Slowly over 1-3 days (unlike serotonin syndrome which has a more acute onset)

  • Altered mental status, 82% of patients, typically agitated delirium with confusion

  • Peripheral muscle rigidity and decreased reflexes. AKA lead pipe rigidity. (As opposed to clonus and hyperreflexia in serotonin syndrome)

  • Hyperthermia (>38C seen in 87% of patients)

  • Can also have tachycardia, labile blood pressures, tachypnea, and tremor

How is it diagnosed?

  • Clinical diagnosis, focus on the timing of symptoms

  • No confirmatory lab test but can see possible elevated CK levels and WBC of 10-40k with a left shift

What else might be on the differential?

  • Sepsis

  • CNS infections

  • Heat stroke

  • Agitated delirium

  • Status eptilepticus

  • Drug induced extrapyramidal symptoms

  • Serotonin syndrome

  • Malignant hyperthermia

What is the treatment?

  • Start with ABC’s

  • Stop all anti-dopaminergic meds and restart pro-dopamine meds if recently stopped

  • Maintain urine output with IV fluids if needed to avoid rhabdomyolysis

  • Active or passive cooling if needed

  • Benzodiazapines, such as lorazepam 1-2 mg IV q 4hrs

What are active medical therapies?

  • Controversial treatments

  • Bromocriptine, dopamine agonist

  • Dantrolene, classically used for malignant hyperthermia

  • Amantadine, increases dopamine release

  • Use as a last resort

Dispo?

  • Mortality is around 10% if not recognized and treated

  • Most patients recover in 2-14 days

  • Must wait 2 weeks before restarting any medications

References

  • Oruch, R., Pryme, I. F., Engelsen, B. A., & Lund, A. (2017). Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatric disease and treatment, 13, 161–175. https://doi.org/10.2147/NDT.S118438

  • Tormoehlen, L. M., & Rusyniak, D. E. (2018). Neuroleptic malignant syndrome and serotonin syndrome. Handbook of clinical neurology, 157, 663–675. https://doi.org/10.1016/B978-0-444-64074-1.00039-2

  • Velamoor, V. R., Norman, R. M., Caroff, S. N., Mann, S. C., Sullivan, K. A., & Antelo, R. E. (1994). Progression of symptoms in neuroleptic malignant syndrome. The Journal of nervous and mental disease, 182(3), 168–173. https://doi.org/10.1097/00005053-199403000-00007

  • Ware, M. R., Feller, D. B., & Hall, K. L. (2018). Neuroleptic Malignant Syndrome: Diagnosis and Management. The primary care companion for CNS disorders, 20(1), 17r02185. https://doi.org/10.4088/PCC.17r02185

Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSIII